Biomarkers Predictive of Long-Term Outcome After Ischemic Stroke: A Meta-Analysis
- 1 July 2022
- journal article
- research article
- Published by Elsevier in World Neurosurgery
- Vol. 163, e1-e42
Abstract
No abstract availableKeywords
This publication has 194 references indexed in Scilit:
- Correlation between inflammatory factors and post-stroke pneumonia in diabetic patientsExperimental and Therapeutic Medicine, 2013
- Clinical significance of plasma VEGF value in ischemic stroke - research for biomarkers in ischemic stroke (REBIOS) studyBMC Neurology, 2013
- High-sensitivity troponin assay improves prediction of cardiovascular risk in patients with cerebral ischaemiaJournal of Neurology, Neurosurgery & Psychiatry, 2013
- High‐Sensitivity C‐Reactive Protein is a Strong Risk Factor for Death after Acute Ischemic Stroke among ChineseCNS Neuroscience & Therapeutics, 2012
- Selected acute phase CSF factors in ischemic stroke: findings and prognostic valueBMC Neurology, 2011
- Level of Albuminuria and Risk of Stroke: Systematic Review and Meta-AnalysisCerebrovascular Diseases, 2010
- Admission C – reactive protein after acute ischemic stroke is associated with stroke severity and mortality: The 'Bergen stroke study'BMC Neurology, 2009
- Lipoprotein-Associated Phospholipase A2 Activity and Risk of Recurrent StrokeCerebrovascular Diseases, 2008
- Measuring inconsistency in meta-analysesBMJ, 2003
- Meta-analysis in clinical trialsControlled Clinical Trials, 1986